Home › Prostate Cancer › Washington › Seattle
Prostate Cancer clinical trials in Seattle, WA
44 studies for Prostate Cancer are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
RecruitingPhase 1
- Swedish Medical Center, Seattle
Precision-Based Genomics in Prostate Cancer
RecruitingObservational study
- University of Washington, Seattle
Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Research Center, Seattle
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RecruitingPhase 2/3
- Fred Hutchinson Cancer Research Center, Seattle
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Swedish Medical Center, Seattle
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
RecruitingPhase 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
RecruitingPhase 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
RecruitingPhase 3
- VA Puget Sound Health Care System ( Site 0054), Seattle
- Fred Hutchinson Cancer Center ( Site 0060), Seattle
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
RecruitingObservational study
- University of Washington Medical Center, Seattle
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- University of Washington, Fred Hutchinson Cancer Center, Seattle
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
RecruitingPhase 2
- University of Washington, Seattle
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
RecruitingPhase 3
- Fred Hutchinson Cancer Center, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
RecruitingPhase 1
- Investigational Site Number: 400, Seattle
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Swedish Medical Center-Ballard Campus, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- Swedish Medical Center-First Hill, Seattle
- and 1 more
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
RecruitingPhase 3
- Swedish Medical Center-First Hill, Seattle
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
RecruitingPhase 2
- Swedish Medical Center-First Hill, Seattle
Prostate Active Surveillance Study
RecruitingObservational study
- Veterans Affairs Puget Sound Health Care System, Seattle
- University of Washington, Seattle
Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
RecruitingPhase 2
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
RecruitingPhase 2
- University of Washington Medical Center, Seattle
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
RecruitingPhase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- and 4 more
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center, Seattle
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
RecruitingPhase 2
- Fred Hutchinson Cancer Center, Seattle
Impact of DNA Repair Pathway Alterations on Sensitivity to Radium-223 in Bone Metastatic Castration-resistant Prostate Cancer
RecruitingObservational study
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Cell Therapy (STEAP1 CART) With Enzalutamide for the Treatment of Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1/2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
RecruitingObservational studyHealthy volunteers welcome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Supraphysiological Androgen to Enhance Treatment Activity in Metastatic Castration-Resistant Prostate Cancer, SPECTRA Study
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Exercise for Tumor Suppressive Impact in Men With Prostate Cancer at High-Risk of Progression on Active Surveillance: The REMOVE Trial
Recruiting
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- Swedish Medical Center-Ballard Campus, Seattle
- Fred Hutchinson Cancer Center, Seattle
- Swedish Medical Center-Cherry Hill, Seattle
- and 4 more
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
RecruitingPhase 1
- University of Washington, Fred Hutchinson Cancer Center, Seattle
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
RecruitingPhase 2
- Fred Hutch/University of Washington Cancer Consortium, Seattle
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
RecruitingPhase 2
- VA Puget Sound Health Care System, Seattle
Prostate Cancer Screening for People at Genetic Risk for Aggressive Disease, PATROL Study
RecruitingObservational studyHealthy volunteers welcome
- Fred Hutch/University of Washington Cancer Consortium, Seattle
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
RecruitingPhase 1/2
- Fred Hutchinson Cancer Center, Seattle
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecruitingPhase 1
- Fred Hutchinson Cancer Center, Seattle
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
RecruitingPhase 2
- Swedish Medical Center-Ballard Campus, Seattle
- FHCC South Lake Union, Seattle
- Fred Hutchinson Cancer Research Center, Seattle
- and 4 more
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Seattle
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- FHCC South Lake Union, Seattle
- FHCC at Northwest Hospital, Seattle
- University of Washington Medical Center - Montlake, Seattle
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY104 studies
- Houston, TX76 studies
- Boston, MA61 studies
- Los Angeles, CA61 studies
- St. Louis, MO47 studies
- San Francisco, CA45 studies
- Chicago, IL45 studies
- Philadelphia, PA44 studies
- Nashville, TN43 studies
- Baltimore, MD42 studies
- Washington, DC38 studies
- Dallas, TX36 studies
Other studies in Seattle
- Non-Small Cell Lung Cancer53 studies
- Cancer (all types)50 studies
- Breast Cancer40 studies
- Acute Myeloid Leukemia40 studies
- Metastatic Cancer39 studies
- Colorectal Cancer34 studies
- Lung Cancer33 studies
- Ovarian Cancer31 studies
- Multiple Myeloma22 studies
- Pancreatic Cancer22 studies
- Myelodysplastic Syndromes21 studies
- Bladder Cancer21 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.